Priority Review Voucher Proposal To Be Considered By FDA
Executive Summary
Potential "blockbuster" drugs could receive faster FDA review under a proposed system to encourage development of treatments for neglected diseases
You may also be interested in...
Pfizer, Merck And Sanofi Show Interest In Priority Review Voucher Program
The process for "cashing in" a priority review voucher needs further clarification, three big pharma companies agree
Pfizer, Merck And Sanofi Show Interest In Priority Review Voucher Program
The process for "cashing in" a priority review voucher needs further clarification, three big pharma companies agree
Priority Review “Vouchers” Offered To Firms Developing HIV Drugs In FDA Bill
The Senate's version of FDA user fee reauthorization legislation includes a provision designed to encourage creation of products that treat HIV and other diseases affecting developing countries